Skip to main content
InPharmacy - return to the homepage InPharmacy logo
  • Search
  • Visit InPharmacy on Linked In
  • Visit InPharmacy on Twitter
  • Visit InPharmacy on Facebook
  • Visit InPharmacy on YouTube
Visit the
National Pharmacy Association National Pharmacy Association

Main navigation

  • NPA News
  • Your Pharmacy
  • Member Benefits
  • Topics
Quick links:
  • Home
  • Categories
  • Member Benefits
  • Representing You
Pharmacy Owner / Director
Government Representative
Pharmacy Industry Representative (other)
Media / Press
NPA News

Northern Ireland protocol: NPA calls for medicines deal

Share on
  • Whatsapp
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print
Open-access content Friday 9th July 2021
Brexit flags

Photo by Rocco Dipoppa on Unsplash

The National Pharmacy Association (NPA) today issued a fresh appeal to Brexit negotiators to reach an understanding that will allow manufacturers and suppliers to continue to supply medicines as normal to Northern Ireland.

Under the Northern Ireland protocol, part of the Brexit withdrawal agreement, medicines made in UK have to be licensed separately for use in the country including separate safety inspections and other checks before they can be given to the public.

It came into force on 1 January 2021, and is now part of international law.

The NPA board discussed this issue during its board meetings on 28-29 June.  NPA board representative for Northern Ireland, Michael Guerin, said:

“This situation, if unresolved, will be intolerable for NPA members and patients in Northern Ireland. We are deeply concerned that the additional cost and complexity of getting medicines into Northern Ireland will result in some manufacturers and suppliers not bringing products to the market. This could result in reduced stock being available, leading to medicine shortages and an increase in the procurement costs.

“The medicines supply to Northern Ireland is integrated into the UK market and works on a just in time basis.  Close alignment of regulations would help to limit future disruption. We urge the EU and the UK to address this issue urgently and not leave it for patients, carers, pharmacists and GPs to pick up the problem further down the line.

“On behalf of its members the NPA has been working with key stakeholders including the MHRA, Community Pharmacy Northern Ireland (CPNI) and the Healthcare Distribution Association (HDA), to amplify concerns to all parties in the negotiations.”

Other topics discussed at the NPA board this month included the Community Pharmacist Consultation Service, covid costs, supervision and pharmacy IT.  The board also welcomed the chief executive of Community Pharmacy Scotland, Harry McQuillan, who shared his organisation’s vision of a clinically-based future for the sector.
 

Topics:
Representing You
Pharmacy Owner / Director
Government Representative
Pharmacy Industry Representative (other)
Media / Press
NPA News

You might also like...

Today's top reads

Sign up to stay up to date

Subscribe

Why not become a member?

Find out more

Looking for a resource?

Read More
​
FOLLOW US
@NPA1921
National Pharmacy Association
National Pharmacy Association
CONTACT US
InPharmacy
Tel: (+44) 01727 858687
​

NPA

About NPA
Become a member
Services & Support
Events

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Sign in or create an account

Get in touch

Contact us
Advertise with us
Write for InPharmacy

General

Pharmacy Careers
Business Partner
Insurance
Representing You

NPA InPharmacy Logotype

© 2022 • InPharmacy is produced by Redactive Media Group. All rights reserved. Reproduction of any part is not allowed without written permission.

Redactive Media Group Ltd, 71-75 Shelton Street, London WC2H 9JQ

 

 

  • Sign in
  • Create account
  • Business Support & Development
  • Learning & Development
  • Advice & Support
  • Insurance
  • Membership
  • Representing You
  • ADVICE AND SUPPORT
    • Key Notes
    • Patient Safety
    • Regulations and Legislation
    • Diary Dates
    • Pharmacy Services
  • BUSINESS SUPPORT & DEVELOPMENT
    • Technology & Data
    • Employment Law & HR
    • Health & Safety
    • Business Operations
    • Recommended Partners
  • LEARNING & DEVELOPMENT
    • Professional Development
    • You and Your Pharmacy Team
    • New Training Initiatives
  • INSURANCE
    • Business Insurance
    • Personal Insurance
    • Professional Indemnity
  • REPRESENTING YOU
    • Campaigns and lobbying
    • Opinions & Ideas